Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial

Pulmonary Pharmacology and Therapeutics

Volumn 44, Issue , 2017, Pages 30-37

  Rialp Cervera, G ^a   Raurich Puigdevall, J M ^b   Moran Chorro I ^c   Martin Delgado M C ^d   Heras la Calle, G ^d,e   Mas Serra, A ^f   Vallverdu Perapoch I ^g  

^a HOSPITAL SON LLÀTZER   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO DE TORREJÓN   (Spain)

^e HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^f Moises Broggi Hospital Sant Joan d'Espì   (Spain)

^g HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Acetazolamide; COPD; Mechanical ventilation; Metabolic alkalosis; Obesity hypoventilation syndrome

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; BILIRUBIN; CREATININE; PLACEBO; POTASSIUM; PROTHROMBIN; SODIUM;

AGED; ALLERGIC REACTION; ANAPHYLAXIS; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BICARBONATE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD GAS ANALYSIS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL MORTALITY; HUMAN; HYPOKALEMIA; HYPONATREMIA; LEUKOCYTE COUNT; LONG TERM CARE; MALE; METABOLIC ALKALOSIS; MULTICENTER STUDY; NONINVASIVE VENTILATION; OBESITY HYPOVENTILATION SYNDROME; PARESTHESIA; PH; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEIZURE; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIDE EFFECT; SODIUM BLOOD LEVEL; TREATMENT DURATION; VENTILATOR WEANING; ACIDOSIS; BLOOD; CLINICAL TRIAL; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; PROCEDURES; TIME FACTOR;

ACETAZOLAMIDE; ACIDOSIS; AGED; BICARBONATES; BLOOD GAS ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBESITY HYPOVENTILATION SYNDROME; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; TIME FACTORS;

EID: 85015679147     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2017.03.002     Document Type: Article

References (38)

1. [1] Anderson, L.E., Henrich, W.L., Alkalemia-associated morbidity and mortality in medical and surgical patients. South. Med. J. 80 (1987), 729–733.
2. [2] Bahloul, M., Chaari, A., Tounsi, A., Turki, O., Chtara, K., Hamida, C.B., Ghadhoune, H., Dammak, H., Chelly, H., Bouaziz, M., Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation. Int.J.Crit Illn.Inj.Sci. 5 (2015), 3–8.
3. [3] Banga, A., Khilnani, G.C., Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay. COPD 6 (2009), 437–440.
4. [4] Berthelsen, P., Cardiovascular performance and oxyhemoglobin dissociation after acetazolamide in metabolic alkalosis. Intensive Care Med. 8 (1982), 269–274.
5. [5] DeBacker, W.A., Verbraecken, J., Willemen, M., Wittesaele, W., DeCock, W., d.P. Van, Central apnea index decreases after prolonged treatment with acetazolamide. Am.J.Respir. Crit. Care Med. 151 (1995), 87–91.
6. [6] Esteban, A., Anzueto, A., Frutos, F., Alia, I., Brochard, L., Stewart, T.E., Benito, S., Epstein, S.K., Apezteguia, C., Nightingale, P., et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 287 (2002), 345–355.
7. [7] Faisy, C., Meziani, F., Planquette, B., Clavel, M., Gacouin, A., Bornstain, C., Schneider, F., Duguet, A., Gibot, S., Lerolle, N., et al. Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA 315 (2016), 480–488.
8. [8] Faisy, C., Mokline, A., Sanchez, O., Tadie, J.M., Fagon, J.Y., Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med. 36 (2010), 859–863.
9. [9] Fisher, J.D., New York heart association classification. Arch. Intern. Med., 129, 1972, 836.
10. [10] Grupo de Trabajo de Enfermedades Infecciosas y Sepsis de SEMICYUC, Estudio Nacional de Vigilancia de Infección Nosocomial (ENVIN-HELICS). Manual de definiciones y términos. April 2016 Date Last Accessed 20 August 2016 http://hws.vhebron.net/envin-helics/Help%5CManual.pdf.
11. [11] Gulsvik, R., Skjorten, I., Undhjem, K., Holo, L., Frostad, A., Saure, E.W., Lejlic, V., Humerfelt, S., Hansen, G., Bruun, W.T., Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis. Clin. Respir. J. 7 (2013), 390–396.
12. [12] Heming, N., Faisy, C., Urien, S., Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients. Crit. Care, 15, 2011, R213.
13. [13] Heming, N., Urien, S., Fulda, V., Meziani, F., Gacouin, A., Clavel, M., Planquette, B., Faisy, C., Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients. PLoS.One, 9, 2014, e86313.
14. [14] Hodgkin, J.E., Soeprono, F.F., Chan, D.M., Incidence of metabolic alkalemia in hospitalized patients. Crit. Care Med. 8 (1980), 725–728.
15. [15] Hudgel, D.W., Thanakitcharu, S., Pharmacologic treatment of sleep-disordered breathing. Am.J.Respir. Crit. Care Med. 158 (1998), 691–699.
16. [16] Javaheri, S., Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am.J.Respir. Crit. Care Med. 173 (2006), 234–237.
17. [17] Javaheri, S., Shore, N.S., Rose, B., Kazemi, H., Compensatory hypoventilation in metabolic alkalosis. Chest 81 (1982), 296–301.
18. [18] Jones, P.W., Greenstone, M., Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane. Database. Syst. Rev., 2001, CD002881.
19. [19] Khanna, A., Kurtzman, N.A., Metabolic alkalosis. Respir. Care 46 (2001), 354–365.
20. [20] Kiwull-Schone, H.F., Teppema, L.J., Kiwull, P.J., Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Am.J.Respir. Crit. Care Med. 163 (2001), 478–483.
21. [21] Krintel, J.J., Haxholdt, O.S., Berthelsen, P., Brockner, J., Carbon dioxide elimination after acetazolamide in patients with chronic obstructive pulmonary disease and metabolic alkalosis. Acta Anaesthesiol. Scand. 27 (1983), 252–254.
22. [22] Liborio, A.B., Noritomi, D.T., Leite, T.T., de Melo Bezerra, C.T., de Faria, E.R., Kellum, J.A., Increased serum bicarbonate in critically ill patients: a retrospective analysis. Intensive Care Med. 41 (2015), 479–486.
23. [23] Marik, P.E., Kussman, B.D., Lipman, J., Kraus, P., Acetazolamide in the treatment of metabolic alkalosis in critically ill patients. Heart Lung 20 (1991), 455–459.
24. [24] Mazur, J.E., Devlin, J.W., Peters, M.J., Jankowski, M.A., Iannuzzi, M.C., Zarowitz, B.J., Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial. Crit. Care Med. 27 (1999), 1257–1261.
25. [25] Moreno, R.P., Metnitz, P.G., Almeida, E., Jordan, B., Bauer, P., Campos, R.A., Iapichino, G., Edbrooke, D., Capuzzo, M., Le Gall, J.R., SAPS 3–From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 31 (2005), 1345–1355.
26. [26] Moviat, M., Pickkers, P., van der Voort, P.H., van der Hoeven, J.G., Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients. Crit. Care, 10, 2006, R14.
27. [27] Olson, A.L., Zwillich, C., The obesity hypoventilation syndrome. Am. J. Med. 118 (2005), 948–956.
28. [28] Raurich, J.M., Rialp, G., Ibanez, J., Llompart-Pou, J.A., Ayestaran, I., Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO(2) response and acetazolamide treatment effects. Respir. Care 55 (2010), 1442–1448.
29. [29] Rialp, G., Raurich, J.M., Llompart-Pou, J.A., Ayestaran, I., Ibanez, J., Respiratory CO2 response depends on plasma bicarbonate concentration in mechanically ventilated patients. Med. Intensiva 38 (2014), 203–210.
30. [30] Swenson, E.R., Hughes, J.M., Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J.Appl. Physiol. 74 (1993), 230–237.
31. [31] Teppema, L.J., Dahan, A., Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity?. Am.J.Respir. Crit. Care Med. 160 (1999), 1592–1597.
32. [32] Tojima, H., Kunitomo, F., Okita, S., Yuguchi, Y., Tatsumi, K., Kimura, H., Kuriyama, T., Watanabe, S., Honda, Y., Difference in the effects of acetazolamide and ammonium chloride acidosis on ventilatory responses to CO2 and hypoxia in humans. Jpn. J. Physiol. 36 (1986), 511–521.
33. [33] Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am.J.Respir. Crit. Care Med. 187 (2013), 347–365.
34. [34] Vincent, J.L., Moreno, R., Takala, J., Willatts, S., de, M.A., Bruining, H., Reinhart, C.K., Suter, P.M., Thijs, L.G., The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med. 22 (1996), 707–710.
35. [35] Vos, P.J., Folgering, H.T., de Boo, T.M., Lemmens, W.J., van Herwaarden, C.L., Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 7 (1994), 850–855.
36. [36] Wagenaar, M., Vos, P., Heijdra, Y., Teppema, L., Folgering, H., Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest 123 (2003), 1450–1459.
37. [37] Webster, N.R., Kulkarni, V., Metabolic alkalosis in the critically ill. Crit. Rev.Clin.Lab Sci. 36 (1999), 497–510.
38. [38] Wilson, R.F., Gibson, D., Percinel, A.K., Ali, M.A., Baker, G., LeBlanc, L.P., Lucas, C., Severe alkalosis in critically ill surgical patients. Arch. Surg. 105 (1972), 197–203.